Literature DB >> 23158590

Tadalafil for the treatment of benign prostatic hyperplasia: when the moment does not add up.

Steven A Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23158590     DOI： 10.1016/j.eururo.2012.11.004

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

Review 1.  Microvascular dysfunction and efficacy of PDE5 inhibitors in BPH-LUTS.

Authors:  Selim Cellek; Norman E Cameron; Mary A Cotter; Christopher H Fry; Dapo Ilo
Journal:  Nat Rev Urol       Date:  2014-03-11       Impact factor: 14.432

Review 2.  Current use of phosphodiesterase inhibitors in urology.

Authors:  Tariq Said Hakky; Lakshay Jain
Journal:  Turk J Urol       Date:  2015-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.